admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Silo Pharma Signs Agreement to Develop First-in-Class Ketamine Implant Therapeutic

PharmaTher Holdings Provides Corporate Update

Delix Therapeutics Appoints Aaron Koenig, MD as Chief Medical Officer

Wesana Health Announces Voting Results of AGSM

PT414 – Lena Franklin & Jeff Glattstein – The EAST Institute:...

Apex Labs Receives Approval for US-Based Secondary GMP Psilocybin Supplier by...

MIND CURE HEALTH INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF...

MIND CURE AND LNG ENERGY GROUP PROVIDE UPDATE ON PREVIOUSLY ANNOUNCED...

Numinus to Participate in the Healthcare Virtual Conference Presented by Maxim...

BetterLife Continues Progress on BETR-001 IND-Enabling Studies

1...626364...218 Page 63 of 218

AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots...

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

Review: Colorado Psychedelic Cup 2025

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin